Novocol Pharma is a CDMO based in Cambridge, Ontario, Canada. With over 40 years of competence, our team of 600+ employees and modern facilities provide customer value with specialization in sterile injectable cartridge manufacturing. Our capabilities include process scale up, drug development, analytical services, technology transfer and low to high volume commercial manufacturing of biologic and small molecule products. We offer combination product assembly services and, through our affiliate organization, Duoject Medical Systems (www.duoject.com), we design your innovative drug delivery devices. Our global regulatory approvals span USA, Canada, Europe, Middle East and Asia. If your drug development pipeline includes cartridge-based pharmaceuticals, Novocol Pharma should be your trusted partner. We are a proud member of the Septodont group of companies. www.septodont.com
| Website | http://novocolpharma.com |
| Revenue | $46.1 million |
| Employees | 209 (132 on RocketReach) |
| Address | 25 Wolseley Ct, Cambridge, Ontario N1R 6X3, CA |
| Phone | +1 519-623-4800 |
| Technologies |
JavaScript
,
HTML
,
PHP
+11 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing |
| Competitors | Teva Pharmaceuticals, Mylan Belgium, Sandoz, Amgen, Bristol Myers Squibb, Roche, Pfizer, AstraZeneca, Gilead Sciences, Lilly India +36 more (view full list) |
Looking for a particular Novocol Pharma employee's phone or email?
The Novocol Pharma annual revenue was $46.1 million in 2026.
Atif Zia is the Chief Operating Officer, Septodont ; President, Novocol Pharma of Novocol Pharma.
132 people are employed at Novocol Pharma.
Novocol Pharma is based in Cambridge, Ontario.